Join our daily newsletter At The Bell to receive exclusive market insights
- Medtech company MedAdvisor (MDR) enters the New Zealand market via a three-year agreement with Green Cross Health
- Green Cross Health is a provider of primary health care services in New Zealand and represents 350 community pharmacies under its Unichem and Life brands
- The agreement will be undertaken in three phases and will result in the rollout of additional MedAdvisor digital solutions to the Green Cross Health network
- MedAdvisor will earn both software-as-a-service (SaaS) fees and transaction fees which are similar to Australian pricing
- Shares in MedAdvisor are up 1.56 per cent on the market and are trading at 32.5 cents
Medtech company MedAdvisor (MDR) has entered the New Zealand market via a three-year agreement with Green Cross Health.
Green Cross Health is a provider of primary health care services in New Zealand and represents 350 community pharmacies under its Unichem and Life brands.
It has over 1.8 million loyalty members and roughly 600,000 users on its SMS script reminder service.
“We are passionately committed to the health and wellness of New Zealand and to provide the best support, care and advice to our communities,” Green Cross CEO Rachael Newfield said.
“Our selection of MedAdvisor is aligned with this commitment given their demonstrated proven solution in multiple markets that is supporting people to take their medication safely, effectively and on time.”
The agreement will be undertaken in three phases and will result in the rollout of additional MedAdvisor digital solutions to the Green Cross Health network.
Further, it provides MedAdvisor with access roughly 40 per cent of the New Zealand pharmacy market.
MedAdvisor will earn both software-as-a-service (SaaS) fees and transaction fees which are similar to Australian pricing.
“We look forward to working closely with Green Cross Health to support their Unichem and Life Pharmacies offering customers an enhanced digital health and retail experience, especially with the introduction of electronic scripts,” MedAdvisor CEO and Managing Director Robert Read said.
“Green Cross Health and MedAdvisor share the common goal of strengthening the relationship between pharmacies and their customers and using technology to provide New Zealanders with a higher level of support, care and advice from their pharmacists.”
Shares in MedAdvisor were up 1.56 per cent on the market and were trading at 32.5 cents at 1:18 pm AEDT.
